AB0056 Hmgb1 regulates hypoxia-inducible factor 1alpha expression and function in synovial fibroblasts from patients with rheumatoid arthritis. (23rd January 2014)
- Record Type:
- Journal Article
- Title:
- AB0056 Hmgb1 regulates hypoxia-inducible factor 1alpha expression and function in synovial fibroblasts from patients with rheumatoid arthritis. (23rd January 2014)
- Main Title:
- AB0056 Hmgb1 regulates hypoxia-inducible factor 1alpha expression and function in synovial fibroblasts from patients with rheumatoid arthritis
- Authors:
- Park, S. Y.
Lee, H. R.
Kim, H. Y.
Baek, S. H.
Kim, C. D. - Abstract:
- Abstract : Background: High mobility group box chromosomal protein 1 (HMGB1) is a nuclear DNA binding protein that is secreted into extracellular medium by cellular activation and proinflammatory response, and promotes inflammation. HMGB1 is known as ligand for TLR4 that produces TNF-a and IL-8 (1, 2 ). Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor which is composed of an alpha and beta subunit. HIF-1 has been reported as regulator of angiogenesis in rheumatoid arthritis (RA) (3, 4 ). Objectives: We investigated the role and molecular mechanism of HMGB1 in the expression and function of HIF-1α in synovial fibroblasts from patients with RA. Methods: HIF-1 activity and VEGF expression were measured by ELISA. Signaling and molecular events were analyzed by immunoblotting. Results: The expression of extracellular HMGB1 was increased in synovium of RA patients than OA patients. Treatment of RA synovial fibroblasts with HMGB1 increased HIF-1αexpression and HIF-1 activity. HMGB1 mediated production of VEGF was dependent upon HIF-1. When TLR4 was blocked by TLR4 siRNA or anti-TLR4 antibody, HIF-1αdidn't be increased, leading to abolish the increase in VEGF production. Image/graph: Conclusions: Our results suggest that HMGB1stimulation of HIF-1α expression and activity results in VEGF expression that is dependent upon TLR4. References: Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatinAbstract : Background: High mobility group box chromosomal protein 1 (HMGB1) is a nuclear DNA binding protein that is secreted into extracellular medium by cellular activation and proinflammatory response, and promotes inflammation. HMGB1 is known as ligand for TLR4 that produces TNF-a and IL-8 (1, 2 ). Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor which is composed of an alpha and beta subunit. HIF-1 has been reported as regulator of angiogenesis in rheumatoid arthritis (RA) (3, 4 ). Objectives: We investigated the role and molecular mechanism of HMGB1 in the expression and function of HIF-1α in synovial fibroblasts from patients with RA. Methods: HIF-1 activity and VEGF expression were measured by ELISA. Signaling and molecular events were analyzed by immunoblotting. Results: The expression of extracellular HMGB1 was increased in synovium of RA patients than OA patients. Treatment of RA synovial fibroblasts with HMGB1 increased HIF-1αexpression and HIF-1 activity. HMGB1 mediated production of VEGF was dependent upon HIF-1. When TLR4 was blocked by TLR4 siRNA or anti-TLR4 antibody, HIF-1αdidn't be increased, leading to abolish the increase in VEGF production. Image/graph: Conclusions: Our results suggest that HMGB1stimulation of HIF-1α expression and activity results in VEGF expression that is dependent upon TLR4. References: Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996, 54:35-100. Hamada T, Torikai M, Kuwazuru A, et al. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum 2008, 58:2675-2685, Imtiyaz HZ, Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 2010, 345:105-120. Giatromanolaki A, Sivridis E, Maltezos E, et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003, 5:R193–201. Disclosure of Interest: None Declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 72:Supplement 3(2013)
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 72:Supplement 3(2013)
- Issue Display:
- Volume 72, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 72
- Issue:
- 3
- Issue Sort Value:
- 2013-0072-0003-0000
- Page Start:
- A802
- Page End:
- A803
- Publication Date:
- 2014-01-23
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2013-eular.2379 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18206.xml